Katey Owen

Director/Board Member at ADAPTIVE BIOTECHNOLOGIES CORPORATION

Net worth: 2 M $ as of 30/06/2026

57 year

68 connections

Health Technology

Finance

Consumer Services

Profile

Katey Owen is currently an Independent Director at Adaptive Biotechnologies Corp.
since 2021 and Director-Vaccine Development at Gates Foundation Trust since 2022.
Formerly, Dr. Owen was Senior Director at Merck & Co., Inc. Education includes undergraduate and doctorate degrees from Purdue University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ADAPTIVE BIOTECHNOLOGIES CORP. 0.05%	01/04/2026	72,629 ( 0.05% )	2 M $	30/06/2026

Katey Owen active positions

Companies	Position	Start
ADAPTIVE BIOTECHNOLOGIES CORPORATION	Director/Board Member	17/03/2021
Gates Foundation Trust Gates Foundation Trust Financial ConglomeratesFinance Foundation	Corporate Officer/Principal	01/08/2013

All active positions of Katey Owen

Former positions of Katey Owen

Companies	Position	End
MERCK & CO., INC.	Corporate Officer/Principal	-

See the detail of Katey Owen's experience

Training of Katey Owen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Katey Owen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Merck & Co., Inc. Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines	Health Technology
Gates Foundation Trust Gates Foundation Trust Financial ConglomeratesFinance Foundation	Finance
Purdue University Purdue University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Adaptive Biotechnologies Corp. Adaptive Biotechnologies Corp. BiotechnologyHealth Technology Develops minimal residual disease and immune medicine	Health Technology